
EMBO Member
Ruth Arnon
EMBO 1973 | MemPubC 02–04
Weizmann Institute of Science, Rehovot, Israel
Research on multiple sclerosis and influenza vaccine
My lab made significant contributions to the fields of vaccine development and cancer research, and to the study of parasitic diseases. I co-developed Copaxone®, a multiple sclerosis (MS) drug currently marketed worldwide. I continue to focus on the understanding of the mechanism by which Copaxone is exerting its beneficial effect. I am also developing a synthetic vaccine to provide broad range immunity against infection with influenza viruses.
Keywords
Vaccines / immunotargeting of drugs / autoimmunity / multiple sclerosis / immunoparasitology